Is Zenas BioPharma, Inc. (ZBIO) a Buy, Sell, or Hold?
NASDAQ : ZBIO
Zenas BioPharma, Inc.
$29.53 USD
$1.29 (4.57%)
- Volume
- 718.8K
- Average Volume
- 742.7K
- Market Capitalization
- $1.32B
- P/E Ratio
- -3.25
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $44.60
- Year Low
- $13.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.94
Analyst Consensus Summary
Consensus Rating
Strong Sell
5 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
34.2%
vs Current Price
Price Target
$22.00
Average TargetPrice Target Range
Lowest Target
$22.00
34.2% UPSIDE
Average Target
$22.00
Median Estimate
Highest Target
$22.00
34.2% UPSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 5
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 4 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Roger Song | $48 | $16.61 | 2026-01-06 04:59 AM | 189.0% |
| Morgan Stanley | Sean Laaman | $34 | $31.646 | 2025-10-27 12:32 PM | 7.4% |
| Jefferies | Roger Song | $52 | $31.8 | 2025-10-27 11:02 AM | 63.5% |
| Jefferies | Roger Song | $35 | $18.7 | 2024-10-08 01:18 AM | 87.2% |